Search

everythinglearnresearchcommunity

for

Search:↓

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

The model helps understand scar contraction and develop new treatments.

Seven genes are highly expressed in both germ-line and hematopoietic stem cells.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Targeting impaired Nrf2 signaling might help treat hidradenitis suppurativa early on.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Blocking CXCR4 may help treat hidradenitis suppurativa.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

HS needs personalized treatment plans and more research.

Keratinocytes contribute to hidradenitis suppurativa by causing inflammation and worsening the condition.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Reduced AhR signaling in HS tunnels leads to persistent inflammation and microbial imbalance.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Matrix changes and increased MMPs contribute to skin inflammation in hidradenitis suppurativa.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Notch1 signaling is impaired in hidradenitis suppurativa, affecting skin and hair cells.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.